Predictors of lymphovascular invasion in estrogen receptor positive/Her-2 negative breast cancer patients treated with neoadjuvant chemotherapy

BACKGROUND/AIM: Lymphovascular invasion (LVI) is considered a high-risk factor for recurrence in early-stage breast cancer, hence examination of LVI in pathological samples is an absolute recommendation. We aim to investigate predictive factors of LVI in pre-neoadjuvant chemotherapy (NAC) patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: ÇAVDAR, Eyyüp, İRİAĞAÇ, Yakup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387951/
https://www.ncbi.nlm.nih.gov/pubmed/36326379
http://dx.doi.org/10.55730/1300-0144.5414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387951/
https://www.ncbi.nlm.nih.gov/pubmed/36326379
http://dx.doi.org/10.55730/1300-0144.5414

Ejemplares similares